The Use of Chest Magnetic Resonance Imaging in Malignant Pleural Mesothelioma Diagnosis.
magnetic resonance imaging
malignant pleural disease
malignant pleural mesothelioma
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
19 Mar 2022
19 Mar 2022
Historique:
received:
08
02
2022
revised:
15
03
2022
accepted:
16
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
In recent years, many articles have demonstrated that magnetic resonance imaging (MRI) may be performed successfully in the study of the chest. The aim of this study was to evaluate the potential role of MRI in the differentiation of benign from malignant pleural disease with a special focus on malignant pleural mesothelioma and on MRI protocols. A systematic literature search was performed to find original articles about chest MRI in patients with either benign or malignant pleural disease. We retrieved 1246 papers and 17 studies were finally identified as being in accordance with our purpose. For a morphologic assessment, T1-weighted and T2-weighted sequences were usually performed, eventually associated with T1 post-contrast sequences for better detection of pleural lesions. Functional sequences such as Diffusion Weighting Imaging (DWI), associated with the evaluation of Apparent Diffusion Coefficient (ADC) maps, were lately and gradually introduced in chest MRI protocols and their potentiality in differentiating benign from malignant disease has been investigated by many authors. Many progresses have been performed to improve quality images and diagnostic performances of MRI. A better and early identification of pleural disease may be obtained, providing MRI as a possible tool that can differentiate malignant from benign pleural disease without using invasive procedures.
Identifiants
pubmed: 35328305
pii: diagnostics12030750
doi: 10.3390/diagnostics12030750
pmc: PMC8946868
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
AJR Am J Roentgenol. 2010 Aug;195(2):W125-30
pubmed: 20651171
Cancers (Basel). 2019 Jun 12;11(6):
pubmed: 31212757
Acta Radiol. 2001 Sep;42(5):502-7
pubmed: 11552888
Cancers (Basel). 2020 Jun 08;12(6):
pubmed: 32521645
Cancers (Basel). 2021 Aug 30;13(17):
pubmed: 34503186
Semin Ultrasound CT MR. 2017 Dec;38(6):559-570
pubmed: 29179896
Eur Respir Rev. 2016 Dec;25(142):472-486
pubmed: 27903668
Eur Respir Rev. 2021 Nov 17;30(162):
pubmed: 34789461
Radiology. 2015 Feb;274(2):576-84
pubmed: 25243538
Eur Radiol. 2008 Aug;18(8):1635-43
pubmed: 18369634
J Magn Reson Imaging. 2017 Sep;46(3):769-782
pubmed: 28117923
Lung Cancer. 2013 Nov;82(2):190-6
pubmed: 24018024
Chest. 2000 Sep;118(3):604-9
pubmed: 10988179
Invest Radiol. 2004 Sep;39(9):554-64
pubmed: 15308938
Lung Cancer. 2016 Nov;101:48-58
pubmed: 27794408
Lung Cancer. 2016 Apr;94:40-5
pubmed: 26973205
Virchows Arch. 2021 Jan;478(1):59-72
pubmed: 33475835
J Thorac Imaging. 2016 Jan;31(1):37-42
pubmed: 26502346
Radiol Oncol. 2010 Jun;44(2):92-6
pubmed: 22933897
Lung Cancer. 2015 Nov;90(2):148-54
pubmed: 26298162
Invest Radiol. 2006 May;41(5):443-8
pubmed: 16625107
Radiographics. 2011 Oct;31(6):1773-91
pubmed: 21997994
Lancet Oncol. 2018 Mar;19(3):e161-e172
pubmed: 29508763
Radiology. 2012 Jun;263(3):884-92
pubmed: 22535562
Curr Treat Options Oncol. 2008 Jun;9(2-3):147-57
pubmed: 18709470
Cancer Imaging. 2019 Feb 27;19(1):10
pubmed: 30813957
Int J Surg. 2021 Apr;88:105906
pubmed: 33789826
Eur Radiol. 2021 Dec;31(12):9038-9047
pubmed: 34047851
Lung Cancer. 2018 Apr;118:48-56
pubmed: 29572002
Curr Opin Oncol. 2021 Jan;33(1):80-86
pubmed: 33186182
Clin Radiol. 2020 Jun;75(6):423-432
pubmed: 32081346
AJR Am J Roentgenol. 2020 Jul;215(1):94-104
pubmed: 32348181